University Hospital of Lausanne-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2017

  1. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

2015

  1. Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet

    Leukemia, Vol. 29, Núm. 5, pp. 1084-1091

2011

  1. Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

    Leukemia, Vol. 25, Núm. 1, pp. 110-120

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051

2001

  1. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients

    Clinical Infectious Diseases, Vol. 32, Núm. 11, pp. 1532-1537

1996

  1. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer

    Antimicrobial Agents and Chemotherapy, Vol. 40, Núm. 5, pp. 1108-1115

1995

  1. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer

    Antimicrobial Agents and Chemotherapy, Vol. 39, Núm. 2, pp. 445-452